Anthony Walsh, PhD Principal
Prior to joining BioInnovation, he was an associate at the Boston-based crossover healthcare investor RA Capital Management, where he gained extensive experience in conducting due diligence on healthcare and biotechnology
companies, with a particular interest in CNS and autoimmune indications. He holds a Bachelor’s degree in Biochemistry from Trinity College, Dublin,
and a PhD in Biophysics from Oxford University and conducted postdoctoral research at Boston University and Harvard University.